Literature DB >> 599366

Phenytoin intoxication during concurrent diazepam therapy.

H J Rogers, R A Haslam, J Longstreth, P S Lietman.   

Abstract

Phenytoin elimination is a saturable process obeying Michaelis-Menten kinetics. Plasma phenytoin levels are not related linearly to dose, and small changes in enzyme activity produced by concurrent drug therapy could alter plasma levels. Two cases of phenytoin intoxication associated with simultaneous administration of diazepam are reported. Intravenous phenytoin infusions were given and the apparent K(m) and V(max) computed from the resulting plasma phenytoin levels. In one case `K(m)' and `V(max)' were 0.8 μmol/1 and 1.3 μmol/1/hour respectively during concurrent diazepam administration, and 50.3 μmol/1 and 4.4 μmol/1/hour after discontinuation of diazepam. In the second case phenytoin infusion with diazepam gave `K(m)' and `V(max)' values of 0.012 μmol/1 and 0.95 μmol/1/hour. Without diazepam these were 28.8 μmol/1 and 0.92 μmol/1/hour respectively.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 599366      PMCID: PMC492863          DOI: 10.1136/jnnp.40.9.890

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.

Authors:  H KUTT; W WINTERS; R KOKENGE; F MCDOWELL
Journal:  Arch Neurol       Date:  1964-12

2.  Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction.

Authors:  H Kutt; K Verebely
Journal:  Biochem Pharmacol       Date:  1970-03       Impact factor: 5.858

3.  Choreoathetosis and diphenylhydantoin intoxication.

Authors:  E Shuttleworth; G Wise; G Paulson
Journal:  JAMA       Date:  1974-11-25       Impact factor: 56.272

4.  Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.

Authors:  S A Kaplan; M L Jack; K Alexander; R E Weinfeld
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

5.  Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

Authors:  N Gerber; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-05

6.  Serum folic acid and phenytoin levels in permanently hospitalized epileptic patients receiving anticonvulsant drug therapy.

Authors:  J Kariks; S W Perry; D Wood
Journal:  Med J Aust       Date:  1971-08-14       Impact factor: 7.738

7.  Pharmacokinetics of diazepam in dogs, mice and humans.

Authors:  E van der Klejin; J M van Rossum; E T Muskens; N V Rijntjes
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

8.  Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients.

Authors:  H Kutt; F McDowell
Journal:  JAMA       Date:  1968-03-11       Impact factor: 56.272

9.  Interaction between phenytoin and the benzodiazepines.

Authors:  F J Vajda; R J Prineas; R R Lovell
Journal:  Br Med J       Date:  1971-02-06

10.  Effect of dosage increments on blood phenytoin concentrations.

Authors:  F Bochner; W D Hooper; J H Tyrer; M J Eadie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-12       Impact factor: 10.154

View more
  6 in total

Review 1.  Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.

Authors:  P Loiseau
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

Review 2.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Factors influencing the activity and fate of benzodiazepines in the body.

Authors:  E van der Kleijn; T B Vree; A M Baars; R Wijsman; L C Edmunds; H J Knop
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

Review 4.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 5.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

6.  Application of modified Michaelis - Menten equations for determination of enzyme inducing and inhibiting drugs.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-11       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.